YBX1 and lung adenocarcinoma: Next, we certified the assumptive mechanisms that YBX1 as the transcriptional activator to accelerate expression of CDC25a, and then the cell cycle, growth and apoptosis in human lung adenocarcinoma cells as well as the inhibition of YBX1 on the growth of xenografts in mice were tested.